Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?
The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.
Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.
"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.
TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.
As the United States continues to move toward quality-based care, ACOs need to rethink the way they attribute care to cardiologists and other members of the heart team.
“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.
Former principal assistant deputy chief of the U.S. Department of Justice's Healthcare Fraud Unit, Lisa Miller, explains what the DOJ is looking for in healthcare fraud cases.
